Zahedan Journal of Research in Medical Sciences

Published by: Kowsar

The Inflammatory Response to Cigarette Smoking Versus Inhaled Opium in the Liver: An Experimental Study

Mohammad Masoomi 1 , Marzieh Mirtajaddini 1 , Reza Malekpur-Afshar 2 , * , Gholamabbas Mohammadi 3 , Ali Mostafavi 4 and Hasan Azizi 5
Authors Information
1 Department of Cardiology, Neurosciences Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, IR Iran
2 Department of Pathology, Neurosciences Research Center, Kerman University of Medical Sciences, Kerman, IR Iran
3 Department of Biochemistry, Physiology Research Center, Kerman University of Medical Sciences, Kerman, IR Iran
4 Department of Chemistry, Shahid Bahonar University of Kerman, Kerman, IR Iran
5 Kerman University of Medical Sciences, Kerman, IR Iran
Article information
  • Zahedan Journal of Research in Medical Sciences: September 28, 2015, 17 (9); e1058
  • Published Online: September 26, 2015
  • Article Type: Research Article
  • Received: January 30, 2014
  • Accepted: April 6, 2014
  • DOI: 10.17795/zjrms-1058

To Cite: Masoomi M, Mirtajaddini M, Malekpur-Afshar R, Mohammadi G, Mostafavi A, et al. The Inflammatory Response to Cigarette Smoking Versus Inhaled Opium in the Liver: An Experimental Study, Zahedan J Res Med Sci. 2015 ; 17(9):e1058. doi: 10.17795/zjrms-1058.

Copyright © 2015, Zahedan University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Kharchenko NK, Synyts'kyi VN, Kovtun TV. [Comparative analysis of the effects of alcoholism and opium addiction on liver function]. Fiziol Zh. 2001; 47(2): 81-6[PubMed]
  • 2. Mahmoodi M, Hosseini-Zijoud SM, Hosseini J, Sayyadi A, Hajizadeh M, Hassanshahi G, et al. Opium withdrawal and some blood biochemical factors in addicts' individuals. Advances in Biological Chemistry. 2012; 2(2): 167-70[DOI]
  • 3. Farahmand H, PourGholami M, Fathollah MS. Chronic extrahepatic bile duct dilatation: sonographic screening in the patients with opioid addiction. Korean J Radiol. 2007; 8(3): 212-5[PubMed]
  • 4. Gaskari SA, Mani AR, Ejtemaei-Mehr S, Namiranian K, Homayoun H, Ahmadi H, et al. Do endogenous opioids contribute to the bradycardia of rats with obstructive cholestasis? Fundam Clin Pharmacol. 2002; 16(4): 273-9[PubMed]
  • 5. Kiani S, Ebrahimkhani MR, Shariftabrizi A, Doratotaj B, Payabvash S, Riazi K, et al. Opioid system blockade decreases collagenase activity and improves liver injury in a rat model of cholestasis. J Gastroenterol Hepatol. 2007; 22(3): 406-13[DOI][PubMed]
  • 6. Li Y, Zhang T, Douglas SD, Lai JP, Xiao WD, Pleasure DE, et al. Morphine enhances hepatitis C virus (HCV) replicon expression. Am J Pathol. 2003; 163(3): 1167-75[DOI][PubMed]
  • 7. Park HJ, Chung MY, Koo SI, Bruno RS. Green tea extract (GTE) attenuates adipose inflammation by restoring glutathione redox status in high fat diet-induced nonalcoholic fatty liver disease (NAFLD). FASEB J. 2010; 24: 14-8
  • 8. El-Dardiry SA, Shafik SR, Wagih A, Amir el AM, Kassem GK, Atef G, et al. Cigarette smoking induced liver insult concomitant with inflammatory mediators in serum crevicular fluid and bronchio alveolar lavage of schistosomal diabetic subjects with history of bronchial asthma. J Egypt Soc Parasitol. 2007; 37(2 Suppl): 723-40[PubMed]
  • 9. Wannamethee SG, Shaper AG. Cigarette smoking and serum liver enzymes: the role of alcohol and inflammation. Ann Clin Biochem. 2010; 47: 321-6[DOI][PubMed]
  • 10. Duysen EG, Li B, Carlson M, Li YF, Wieseler S, Hinrichs SH, et al. Increased hepatotoxicity and cardiac fibrosis in cocaine-treated butyrylcholinesterase knockout mice. Basic Clin Pharmacol Toxicol. 2008; 103(6): 514-21[DOI][PubMed]
  • 11. Sandt L. Caring ambassadors hepatitis C choices. 2008; : 28-9
  • 12. Bailey SM, Mantena SK, Millender-Swain T, Cakir Y, Jhala NC, Chhieng D, et al. Ethanol and tobacco smoke increase hepatic steatosis and hypoxia in the hypercholesterolemic apoE(-/-) mouse: implications for a "multihit" hypothesis of fatty liver disease. Free Radic Biol Med. 2009; 46(7): 928-38[PubMed]
  • 13. Zhang WZ, Venardos K, Chin-Dusting J, Kaye DM. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress. Hypertension. 2006; 48(2): 278-85[DOI][PubMed]
  • 14. El-Zayadi AR. Heavy smoking and liver. World J Gastroenterol. 2006; 12(38): 6098-101[PubMed]
  • 15. Hezode C, Lonjon I, Roudot-Thoraval F, Mavier JP, Pawlotsky JM, Zafrani ES, et al. Impact of smoking on histological liver lesions in chronic hepatitis C. Gut. 2003; 52(1): 126-9[PubMed]
  • 16. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology. 2001; 34(1): 121-5[DOI][PubMed]
  • 17. Zein CO, Beatty K, Post AB, Logan L, Debanne S, McCullough AJ. Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: A cross validated retrospective assessment. Hepatology. 2006; 44(6): 1564-71[DOI][PubMed]
  • 18. Zhu K, Moriarty C, Caplan LS, Levine RS. Cigarette smoking and primary liver cancer: a population-based case-control study in US men. Cancer Causes Control. 2007; 18(3): 315-21[DOI][PubMed]
  • 19. Zhang J, Liu Y, Shi J, Larson DF, Watson RR. Side-stream cigarette smoke induces dose-response in systemic inflammatory cytokine production and oxidative stress. Exp Biol Med (Maywood). 2002; 227(9): 823-9[PubMed]
  • 20. Systemic Inflammation. Conferencias Magistrales. : 91-100
  • 21. Pol O, Puig MM. Expression of opioid receptors during peripheral inflammation. Curr Top Med Chem. 2004; 4(1): 51-61[PubMed]
  • 22. Chakass D, Philippe D, Erdual E, Dharancy S, Malapel M, Dubuquoy C, et al. micro-Opioid receptor activation prevents acute hepatic inflammation and cell death. Gut. 2007; 56(7): 974-81[DOI][PubMed]
  • 23. Tang B, Zhang Y, Liang R, Yuan P, Du J, Wang H, et al. Activation of the delta-opioid receptor inhibits serum deprivation-induced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway. Int J Mol Med. 2011; 28(6): 1077-85[DOI][PubMed]
  • 24. Ebrahimkhani MR, Kiani S, Oakley F, Kendall T, Shariftabrizi A, Tavangar SM, et al. Naltrexone, an opioid receptor antagonist, attenuates liver fibrosis in bile duct ligated rats. Gut. 2006; 55(11): 1606-16[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments